Western blot analysis of the mTOR and STAT3 survival pathways showed a significant reduction in p‐mTOR and p‐STAT3 in both LP‐1 and XG‐2 multiple myeloma cells treated with propranolol (Figure 2G and supplementary material, Figure S2). Here, MTOR is linked to AL amyloidosis.